Evidence map›Paper›PMID 35145390›Full record

ArticleFrontiers in aging neuroscience2021

Development of a Sex-Specific Risk Scoring System for the Prediction of Cognitively Normal People to Patients With Mild Cognitive Impairment (SRSS-CNMCI).

Wen Luo, Hao Wen, Shuqi Ge, Chunzhi Tang, Xiufeng Liu, Liming Lu

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wen LuoSchool of Medical Information Engineering, Guangzhou University of Chinese Medicine, Guangzhou, China.
Hao WenDepartment of Neurology, The Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Shuqi GeEvidence-Based Medicine and Data Science Centre, Guangzhou University of Chinese Medicine, Guangzhou, China.
Chunzhi TangEvidence-Based Medicine and Data Science Centre, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiufeng LiuSchool of Medical Information Engineering, Guangzhou University of Chinese Medicine, Guangzhou, China.
Liming LuEvidence-Based Medicine and Data Science Centre, Guangzhou University of Chinese Medicine, Guangzhou, China.

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI REISA A. SPERLING · 2010 to 2026
$50.2M
NIA NIH HHS P01 AG036694
6 · The paper itself

Abstract

objectiveWe aimed to develop a sex-specific risk scoring system, abbreviated as SRSS-CNMCI, for the prediction of the conversion of cognitively normal (CN) people into patients with Mild Cognitive Impairment (MCI) to provide a reliable tool for the prevention of MCI.

methodsCN at baseline participants 61-90 years of age were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database with at least one follow-up. Multivariable Cox proportional hazards models were used to identify the major risk factors associated with the conversion from CN to MCI and to develop the SRSS-CNMCI. Receiver operating characteristic (ROC) curve analysis was used to determine risk cutoff points corresponding to an optimal prediction. The results were externally validated, including evaluation of the discrimination and calibration in the Harvard Aging Brain Study (HABS) database.

resultsA total of 471 participants, including 240 female (51%) and 231 male participants (49%) aged from 61 to 90 years, were included in the study cohort. The final multivariable models and the SRSS-CNMCI included age,

conclusionThe SRSS-CNMCI performs well in various cohorts and provides an accurate prediction and a generalization.

Indexed as

Alzheimer’s disease (AD)cognitively normal (CN)conversionmild cognitive impairment (MCI)scoring systemsex-specific

Identifiers

PMID35145390
PMCPMC8823413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.